ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Targeting unfolded protein response using albumin-encapsulated nanoparticles attenuates temozolomide resistance in glioblastoma

Kiang, Karrie Mei-Yee; Tang, Wanjun; Song, Qingchun; Liu, Jiaxin; Li, Ning; Lam, Tsz-Lung; Shum, Ho Cheung; Zhu, Zhiyuan*; Leung, Gilberto Ka-Kit*南方医科大学
British Journal of Cancer2023-5-11DOI: 10.1038/s41416-023-02225-x
6被引10阅读
引用收藏
分享

摘要

BackgroundChemoresistant cancer cells frequently exhibit a state of chronically activated endoplasmic reticulum (ER) stress. Engaged with ER stress, the unfolded protein response (UPR) is an adaptive reaction initiated by the accumulation of misfolded proteins. Protein disulfide isomerase (PDI) is a molecular chaperone known to be highly expressed in glioblastomas with acquired resistance to temozolomide (TMZ). We investigate whether therapeutic targeting of PDI provides a rationale to overcome chemoresistance.MethodsThe activity of PDI was suppressed in glioblastoma cells using a small molecule inhibitor CCF642. Either single or combination treatment with TMZ was used. We prepared nanoformulation of CCF642 loaded in albumin as a drug carrier for orthotopic tumour model.ResultsInhibition of PDI significantly enhances the cytotoxic effect of TMZ on glioblastoma cells. More importantly, inhibition of PDI is able to sensitise glioblastoma cells that are initially resistant to TMZ treatment. Nanoformulation of CCF642 is well-tolerated and effective in suppressing tumour growth. It activates cell death-triggering UPR beyond repair and induces ER perturbations through the downregulation of PERK signalling. Combination treatment of TMZ with CCF642 significantly reduces tumour growth compared with either modality alone.ConclusionOur study demonstrates modulation of ER stress by targeting PDI as a promising therapeutic rationale to overcome chemoresistance.

学科与关键词

关键词
DISULFIDE-ISOMERASEDNA-REPAIRINHIBITIONEXPRESSIONSURVIVALDELIVERYSTRESS
相关
加载中…
  • Tubeimoside-I sensitizes temozolomide-resistant glioblastoma cells to chemotherapy by reducing MGMT expression and suppressing EGFR induced PI3K/Akt/mTOR/NF-κB-mediated signaling pathway
    Tang, Qingfa; Cao, Haihong; Tong, Ni; Liu, Yuanliang; Wang, Wanyu; Zou, Yuheng; Xu, Lanyang; Zeng, Zhiyun; Xu, Wei; Yin, Zhixin; Ma, Wenjuan*; Wang, Qirui*PHYTOMEDICINE, 2022, 99: 154016.被引 17
  • Albumin-bound paclitaxel augment temozolomide treatment sensitivity of glioblastoma cells by disrupting DNA damage repair and promoting ferroptosis
    Qu, Shanqiang; Qi, Songtao; Zhang, Huayang; Li, Zhiyong; Wang, Kaicheng; Zhu, Taichen; Ye, Rongxu; Zhang, Wanghao; Huang, Guanglong*; Yi, Guo-zhong*JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42(1): 285.被引 1
  • Enhanced Efficacy of Temozolomide Loaded by Tetrahedral Framework DNA Nanoparticle in Therapy for Glioblastoma.
    Fu Wei; You Chao; Ma Lu; Li Hao; Ju Yan; Guo Xi; Shi Sirong; Zhang Tao; Zhou Ronghui; Lin Yunfeng2019.
查看全部 →

发表信息

论文状态
公开发表
期刊
British Journal of Cancer
发表日期
2023-05-11
卷期
第 128 卷, 第 10 期
页码
1955-1963
DOI
10.1038/s41416-023-02225-x
语言
ENGLISH
成果收录
SCIE
资助标注
Health and Medical Research Fund (HMRF) of the Food and Health Bureau (Hong Kong) [08191986]

作者

  • K

    Kiang, Karrie Mei-Yee (第一作者)

    univ hong kong

  • T

    Tang, Wanjun

    univ hong kong

查看全部 9 位作者收起作者
  • S

    Song, Qingchun

    univ hong kong

  • L

    Liu, Jiaxin

    univ hong kong

  • L

    Li, Ning

    southeast univ · univ hong kong

  • L

    Lam, Tsz-Lung

    univ hong kong

  • S

    Shum, Ho Cheung

    univ hong kong

  • Z

    Zhu, Zhiyuan (通讯)

    univ hong kong · southern med univ

  • L

    Leung, Gilberto Ka-Kit (通讯)

    univ hong kong

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417